Former Bose Engineers and STAT Health Founders Raise $5 Million for In-Ear Wearable to Prevent Fainting with 15-Slide Pitch Deck

Date:

Former Bose engineers Daniel Lee and Paul Jin recently raised $5.1 million in seed funding for their new startup, STAT Health. The company aims to help those who suffer from conditions such as postural orthostatic tachycardia syndrome (POTS), chronic fatigue symptoms, and long COVID, which can cause fainting, dizziness, brain fog, headaches, and fatigue when standing up.

STAT Health has developed a tiny in-ear wearable that measures blood flow to the head, providing patients with valuable data on when these episodes occur and how to mitigate them. The device is designed to be worn 24/7, can be left in while sleeping and showering, and can charge via a micro solar panel.

Notably, the wearable was clinically tested at Johns Hopkins University and was found to predict fainting in users minutes before it happens. STAT collect data from its sensors, which users can view in an accompanying mobile app. The app also provides users with an Up Score, which tracks time spent upright, and a Flow Score, which monitors blood flow abnormalities to help users pace their recovery.

Lee says that the wearable and subscription service will cost $50 per month but hopes to offer personalized coaching as the company grows. We are really trying to help you understand your body to live better with these diseases, he said.

With over 13 million Americans affected by these syndromes, STAT Health’s wearable shows significant promise in the market. With funding from BonAngels Venture Partners and other investors, STAT Health is poised to change the way people live with these conditions and make their daily lives more comfortable.

See also  Europe Plans to Implement Guardrails on AI Apps, Including ChatGPT

Frequently Asked Questions (FAQs) Related to the Above News

What is STAT Health?

STAT Health is a startup founded by former Bose engineers Daniel Lee and Paul Jin that aims to help those who suffer from conditions such as postural orthostatic tachycardia syndrome (POTS), chronic fatigue symptoms, and long COVID, which can cause fainting, dizziness, brain fog, headaches, and fatigue when standing up.

What has STAT Health developed?

STAT Health has developed a tiny in-ear wearable that measures blood flow to the head, providing patients with valuable data on when episodes occur and how to mitigate them.

How was STAT Health's wearable clinically tested?

The wearable was clinically tested at Johns Hopkins University and was found to predict fainting in users minutes before it happens.

What does the STAT Health app provide users with?

The app provides users with an Up Score, which tracks time spent upright, and a Flow Score, which monitors blood flow abnormalities to help users pace their recovery.

How much will the wearable and subscription service cost?

The wearable and subscription service will cost $50 per month, but personalized coaching may be offered as the company grows.

How many Americans are affected by the syndromes that STAT Health is targeting?

Over 13 million Americans are affected by these syndromes.

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Advait Gupta
Advait Gupta
Advait is our expert writer and manager for the Artificial Intelligence category. His passion for AI research and its advancements drives him to deliver in-depth articles that explore the frontiers of this rapidly evolving field. Advait's articles delve into the latest breakthroughs, trends, and ethical considerations, keeping readers at the forefront of AI knowledge.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.